Related Experiment Video
Updated: May 21, 2026

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy (PRRT): 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods
Published on: April 24, 2020
Bismuth-213 and actinium-225 -- generator performance and evolving therapeutic applications of two generator-derived
Alfred Morgenstern1, Frank Bruchertseifer, Christos Apostolidis
1European Commission, Joint Research Centre, Institute for Transuranium Elements, 76125 Karlsruhe, Germany. alfred.morgenstern@ec.europa.eu
Abstract:
The alpha emitters (225)Ac and (213)Bi are promising therapeutic radionuclides for application in targeted alpha therapy of cancer and infectious diseases. Both alpha emitters are available with high specific activity from established radionuclide generators. Their favourable chemical and physical properties have led to the conduction of a large number of preclinical studies and several clinical trials, demonstrating the feasibility, safety and therapeutic efficacy of targeted alpha therapy with (225)Ac and (213)Bi. This review describes methods for the production of (225)Ac and (213)Bi and gives an overview of (225)Ac/(213)Bi radionuclide generator systems. Selected preclinical studies are highlighted and the current clinical experience with (225)Ac and (213)Bi is summarized.
Related Concept Videos
Nuclear Transmutation
Imaging Studies II: Positron Emission Tomography and Scintigraphy
Fundamental Principles of PET
Isotopes and Radioisotopes
An isotope containing more...
Types of Radioactivity
Alpha (α) decay is the emission of an α particle from the nucleus. For example, polonium-210 undergoes α decay:
Positron Emission Tomography
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...
Radioactivity and Nuclear Equations
A nuclide of an element has a specific number of protons and...

